Stem cell derived exosome based therapy
– Pioneering Regenerative Biotechnology with Exosome Based Pharmaceutical Platform

The main focusing area we are aiming at is to provide an innovative proprietary regenerative pharmaceutical platform for irreversible diseases. We work closely with medical centers and partner cooperates to identify important issues should be addressed and solve them using our technical expertise. ExosomePlus has successfully demonstrated commercially available high volume exosome isolation technology and its characterization methodology for quality control of isolated EVs. We have an exciting pipeline under pre-clinical study that
address significant unmet needs.